Skip to content

Clinical investigation of ropivacaine with sufentanil for percutaneous transformational endoscopic discectomy

Clinical investigation of ropivacaine with sufentanil for percutaneous transformational endoscopic discectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17011768
Enrollment
Unknown
Registered
2017-06-27
Start date
2015-11-01
Completion date
Unknown
Last updated
2017-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lumbar intervertebral disci

Interventions

Local anesthesia group: local infiltration anesthesia

Sponsors

Shanghai Tenth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 51 Years

Inclusion criteria

Inclusion criteria: At least 18 years of age to suffer intervertebral foramen microscopically

Exclusion criteria

Exclusion criteria: Exclusion criteria included severe cardiopulmonary dysfunction and blood coagulation dysfunction.

Design outcomes

Primary

MeasureTime frame
pain scores;

Countries

China

Contacts

Public ContactCheng Li

Shanghai Tenth People's Hospital

marklisa@163.com+86 15121081239

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 17, 2026